Delivery Order SPE2DB22D2206-SPE2DB23FHW32
Award Date 6/26/23
Potential Completion Date 6/27/23
Potential Value $478
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $71,790 to Amerisourcebergen Drug Corporation for 4561475270 QUETIAPINE ER 300 MG TABLET 60S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the specified location in Conshohocken, Pennsylvania by July 13, 2023 to fulfill DLA's requirements. The parent company, Amerisourcebergen Corporation, will support performance through its Amerisourcebergen...
- The Defense Logistics Agency awarded a $373,290 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561948055 Quetiapine ER 400 mg tablets, 60 count. The order is for the delivery of pharmaceutical products to support the Department of Defense. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with all items to be delivered between August 25-28, 2023. No set aside provisions or subcontractors were identified. The...
- The Defense Logistics Agency awarded a $485.94 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561407319, which is Quetiapine ER 300 mg tablets in 60 count bottles. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 5, 2023 through July 6, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill requirements for Quetiapine, an atypical...
- Amerisourcebergen Drug Corp has been awarded a twenty-nine dollar firm fixed price delivery order contract from the Defense Logistics Agency to provide 4562520922 QUETIAPINE ER 200 MG TABLET 60S. Performance will take place in Conshohocken, Pennsylvania. No set-aside designation was used for this award. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is likely associated with the Defense Logistics Agency's pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred seventy thousand forty dollars to Amerisourcebergen Drug Corporation for the supply of sixty tablets of three hundred milligram quetiapine fumarate. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September eighth through the eleventh of twenty twenty-three. The prime contractor, Amerisourcebergen Drug Corporation, is a division of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,040 to Amerisourcebergen Drug Corporation for the provision of 4561740310 Quetiapine ER 150 mg tablets, 60 count. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania to fulfill DLA requirements. No major subcontractors or set aside designations were indicated. This order is consistent with DLA's mission to...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562867277 QUETIAPINE ER 300 MG TABLET 60S. The $1,262.75 order was awarded on November 20, 2023 and requires completion by November 21, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing indefinite delivery contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,700 to Amerisourcebergen Drug Corporation for the supply of 4561533052 Quetiapine ER 50 mg tablets, 60 count. The order is for a one day period of performance from July 18-19, 2023 to be fulfilled from the contractor's facility located in Conshohocken, Pennsylvania. No set aside designation or subcontracting details were provided. The DLA manages the global supply chain for the United States military and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately ninety-four thousand dollars to Amerisourcebergen Drug Corporation for the supply of 4562031510, Quetiapine ER 150 mg tablets packaged in 60-count bottles. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning September 1 through 5, 2023. As a top pharmaceutical supplier to the U.S. Department of Defense, Amerisourcebergen will deliver this...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $21,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4562146307 quetiapine ER 200 mg tablets (60 count) for use by the Department of Defense. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 12-13, 2023. As a major provider of pharmaceuticals and medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FHW32Delivery Order
The Defense Logistics Agency awarded a $477.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561343831 QUETIAPINE ER 300 MG TABLET 60S. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania under a one-day period of performance beginning June 26, 2023. No additional subcontractors or set aside designations were indicated. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract, which centrally manages pharmaceutical procurement to streamline supply for DOD treatment facilities and military treatment centers worldwide.
Generated 12/24/23, 8:44 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $478 | 6/26/23 |